Pharmazz, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Willowbrook, Illinois, founded and led by pharmacologist Dr. Anil Gulati. The company discovers, develops and commercializes first-in-class therapeutics for critical care and neurovascular medicine, built around two lead small-molecule candidates: centhaquine (Lyfaquin), a resuscitative agent for hypovolemic shock that holds marketing authorization from the Drugs Controller General of India and is licensed to Dr. Reddy's Laboratories for the Indian market, and sovateltide (Tycamzzi), an endothelin-B receptor agonist for cerebral ischemic stroke. Additional pipeline programs target septic shock, acute kidney injury, cardiac arrest, acute spinal cord injury, hypoxic-ischemic encephalopathy and Alzheimer's disease. Pharmazz is a drug-development company, not a software vendor; its public web presence is a corporate and investor brochure site and it operates no developer program, public API, SDK or machine-readable interface.
Pharmazz is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Healthcare.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/pharmazz: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: pharmazz
name: Pharmazz
description: 'Pharmazz, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Willowbrook, Illinois,
founded and led by pharmacologist Dr. Anil Gulati. The company discovers, develops and commercializes first-in-class therapeutics
for critical care and neurovascular medicine, built around two lead small-molecule candidates: centhaquine (Lyfaquin), a
resuscitative agent for hypovolemic shock that holds marketing authorization from the Drugs Controller General of India
and is licensed to Dr. Reddy''s Laboratories for the Indian market, and sovateltide (Tycamzzi), an endothelin-B receptor
agonist for cerebral ischemic stroke. Additional pipeline programs target septic shock, acute kidney injury, cardiac arrest,
acute spinal cord injury, hypoxic-ischemic encephalopathy and Alzheimer''s disease. Pharmazz is a drug-development company,
not a software vendor; its public web presence is a corporate and investor brochure site and it operates no developer program,
public API, SDK or machine-readable interface.'
url: https://raw.githubusercontent.com/api-evangelist/pharmazz/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Healthcare
- Clinical Trials
- Critical Care
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/pharmazz-domain-security.yml
- type: Website
url: https://www.pharmazz.com/
- type: About
url: https://www.pharmazz.com/about-us.php
- type: Contact
url: https://www.pharmazz.com/contact-us.php
- type: Careers
url: https://www.pharmazz.com/career.php
- type: Press
url: https://www.pharmazz.com/press-releases.php
- type: Investors
url: https://www.pharmazz.com/investors.php
- type: Publications
url: https://www.pharmazz.com/publications.php
- type: LinkedIn
url: https://www.linkedin.com/company/pharmazz
- type: Sitemap
url: https://www.pharmazz.com/sitemap.xml
- type: LLMsTxt
url: llms/pharmazz-llms.txt
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 3
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Pharmazz is a clinical-stage drug developer whose entire public presence is a 33-page static PHP brochure site listing
its centhaquine and sovateltide trial programs; there is no /developers, /docs or /api path, no GitHub organization, and
every contract-discovery probe against www.pharmazz.com returned the site's standard 404 page.
evidence:
- url: https://www.pharmazz.com/developers
status: 404
- url: https://www.pharmazz.com/openapi.json
status: 404
- url: https://www.pharmazz.com/.well-known/agent-card.json
status: 404
- url: https://www.pharmazz.com/sitemap.xml
status: 200
checked: '2026-08-26'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.